⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1134016 | 1.00 | — | — | |
| SCHEMBL8652672 | 1.00 | — | — | |
| SCHEMBL13778515 | 0.84 | — | — | |
| SCHEMBL3441345 | 0.84 | — | — | |
| SCHEMBL1263525 | 0.84 | — | — | |
| SCHEMBL11769969 | 0.82 | THRB (0.42) | — | |
| SCHEMBL12459957 | 0.82 | THRB (0.42) | — | |
| SCHEMBL16535939 | 0.81 | — | — | |
| Ethylene Glycol SCHEMBL2197362 | 0.80 | THRB (0.46) | — | |
| SCHEMBL15503338 | 0.80 | USP2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347872-B1 | OLIGO-MODIFIED NUCLEOTIDE ANALOGUES FOR NUCLEIC ACID PREPARATION | ILLUMINA INC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4437125-A1 | RNA AND DNA ANALYSIS USING ENGINEERED SURFACES | Alida Biosciences, Inc. (US) | 2024-10-02 | — | — | EP | claimed |
| CN-118660973-A | RNA and DNA analysis Using engineered surfaces | 阿丽达生物科学公司 | 2024-09-17 | — | — | CN | claimed |
| US-20240271126-A1 | OLIGO-MODIFIED NUCLEOTIDE ANALOGUES FOR NUCLEIC ACID PREPARATION | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-08-15 | — | — | US | claimed |
| EP-4347872-A2 | OLIGO-MODIFIED NUCLEOTIDE ANALOGUES FOR NUCLEIC ACID PREPARATION | ILLUMINA, INC. (US) | 2024-04-10 | — | — | EP | claimed |
| EP-4337331-A1 | MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF | The Broad Institute Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| EP-4314332-A2 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | ModernaTX, Inc. (US) | 2024-02-07 | — | — | EP | claimed |
| CN-117413068-A | Oligonucleotide-modified nucleotide analogs for nucleic acid preparation | 因美纳有限公司 | 2024-01-16 | — | — | CN | claimed |
| WO-2023141474-A9 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| US-11795502-B2 | Method for multiplying nucleic acids | HP HEALTH SOLUTIONS GERMANY GMBH (DE) | 2023-10-24 | — | — | US | claimed |
| WO-1996016972-A1 | PURINE NUCLEOSIDE MODIFICATIONS BY PALLADIUM CATALYZED METHODS | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-06-06 | — | — | WO | claimed |
| WO-1996011937-A1 | PORPHYRIN LABELING OF POLYNUCLEOTIDES | STRATAGENE (US) | 1996-04-25 | — | — | WO | claimed |
| EP-0439182-B1 | Improved method of amplifying target nucleic acids applicable to both polymerase and ligase chain reactions | ABBOTT LAB (US) | 1996-04-24 | — | — | EP | claimed |
| US-5510507-A | COORDINATION CATALYSTS; EFFICIENT ENANTIOSELECTIVITY | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-04-23 | — | — | US | claimed |
| US-5481006-A | PREPARATION OF INTERMEDIATES FOR PHARMACEUTICALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-01-02 | — | — | US | claimed |
| US-5455157-A | Introducing nucleotide labelled with hapten into cell with addition of nonencapsulating cationic liposome, determining incorporation into nucleic acids as function of time | BOEHRINGER MANNHEIM GMBH (DE) | 1995-10-03 | — | — | US | claimed |
| WO-1995024507-A1 | BIOASSAY FOR REVERSE TRANSCRIPTASE INHIBITORS | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 1995-09-14 | — | — | WO | claimed |
| WO-1995018787-A1 | SELECTIVE ASYMMETRIC HYDROGENATION OF DEHYDROAMINO ACID DERIVATIVES USING RHODIUM AND IRIDIUM DIPHOSPHINITE CARBOHYDRATE CATALYST COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-07-13 | — | — | WO | claimed |
| US-5064754-A | Generating specific polynucleotides, determining mucleic acid base composition and terminal base, solving the base seuence u sing an logorithm called the matrix method of analysis | MILLS RANDELL L (US) | 1991-11-12 | — | — | US | claimed |
| EP-0350287-A2 | Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use | NeXstar Pharmaceuticals, Inc. (US) | 1990-01-10 | — | — | EP | claimed |